Treatment of cardiac insufficiency in patients with chronic obstructive lung disease

: Course and systematic long-term noliprel therapy of chronic obstructive lung disease (COLD) complicated by chronic pulmonary heart permitted to arrest or significantly slow down further progress of heart remodeling, impairment of systolic and diastolic function of right and left chamber and to decrease pressure in the pulmonary artery. These changes correlated with an improved clinical picture of the disease, increased tolerance to physical exercise, and reduced frequency of progressive right ventricular insufficiency. The integral indicator of clinical symptoms fell down from 12.54 +/- 0.27 to 9.26 +/- 0.22 by the 12th month of therapy. This finding confirms beneficial effect of noliprel on clinical manifestations of heart failure and substantial improvement of structural and functional parameters of the right heart.